US7914814B2
(en)
*
|
1997-09-17 |
2011-03-29 |
Strategic Science & Technologies, Llc |
Topical delivery of arginine of cause beneficial effects
|
US7629384B2
(en)
*
|
1997-09-17 |
2009-12-08 |
Strategic Science & Technologies, Llc |
Topical delivery of L-arginine to cause beneficial effects
|
WO1999022728A1
(en)
*
|
1997-10-31 |
1999-05-14 |
Arch Development Corporation |
Methods and compositions for regulation of 5-alpha reductase activity
|
US7220427B2
(en)
*
|
1998-07-08 |
2007-05-22 |
Oryxe |
Mixture for transdermal delivery of low and high molecular weight compounds
|
US6946144B1
(en)
*
|
1998-07-08 |
2005-09-20 |
Oryxe |
Transdermal delivery system
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
ITMI991894A1
(it)
*
|
1999-09-09 |
2001-03-09 |
Carlo Ghisalberti |
Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
|
DE10009424A1
(de)
*
|
2000-02-28 |
2001-09-06 |
Henkel Kgaa |
Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
|
US20060121103A1
(en)
*
|
2000-05-11 |
2006-06-08 |
Kenneth Kirby |
Transdermal delivery system
|
FR2811566B1
(fr)
*
|
2000-07-13 |
2003-01-17 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et une vitamine
|
FR2811562B1
(fr)
*
|
2000-07-13 |
2003-03-07 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et un isoflavonoide
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
EP1307232B1
(en)
|
2000-08-03 |
2007-03-07 |
Antares Pharma IPL AG |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
FR2812873B1
(fr)
|
2000-08-11 |
2003-08-01 |
Barry Callebaut France |
Procede de production de polyphenols a partir de feves de cacao
|
EP1180331B1
(en)
*
|
2000-08-16 |
2008-07-09 |
Unilever N.V. |
Blends of isoflavones and flavones
|
DE60134702D1
(de)
|
2000-08-16 |
2008-08-21 |
Unilever Nv |
Mischungen von Isoflavonen und Flavonen
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
FR2815858B1
(fr)
*
|
2000-10-26 |
2003-12-12 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et un agent susceptible d'inhiber l'irritation d'origine neurogene
|
CN1262274C
(zh)
*
|
2000-11-14 |
2006-07-05 |
生命健康科学有限公司 |
磷酸盐衍生物复合物
|
AUPR549901A0
(en)
*
|
2001-06-06 |
2001-07-12 |
Vital Health Sciences Pty Ltd |
Topical formulation containing tocopheryl phosphates
|
FR2818135B1
(fr)
|
2000-12-15 |
2003-02-14 |
Oreal |
Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un carotenoide
|
FR2818148B1
(fr)
|
2000-12-15 |
2005-06-24 |
Oreal |
Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
|
US6607735B2
(en)
|
2000-12-21 |
2003-08-19 |
Johnson & Johnson Consumer Companies, Inc. |
Method for reducing the appearance of dark circles under the eyes
|
NL1017333C2
(nl)
*
|
2001-02-12 |
2002-08-13 |
Gent Natural Products Van |
Cosmetisch resp. farmaceutisch preparaat.
|
US6589591B1
(en)
*
|
2001-07-10 |
2003-07-08 |
Baylor College Of Medicine |
Method for treating medical devices using glycerol and an antimicrobial agent
|
CA2453823C
(en)
*
|
2001-07-27 |
2010-12-21 |
Vital Health Sciences Pty Ltd |
Dermal therapy using phosphate derivatives of electron transfer agents
|
EP1427323A4
(en)
*
|
2001-08-20 |
2004-09-15 |
Univ Virginia |
USE OF S-NITROSOTHIOL SIGNALING TO TREAT BREATH CONTROL DISORDERS
|
US8795716B2
(en)
|
2001-10-01 |
2014-08-05 |
The Procter & Gamble Company |
Skin care compositions on a thin sanitary napkin
|
CN1604772A
(zh)
*
|
2001-12-13 |
2005-04-06 |
生命健康科学有限公司 |
化合物的透皮转运
|
AU2003220240A1
(en)
*
|
2002-03-13 |
2003-09-29 |
Biophysica, Inc. |
Boswellin compositions enhanced with 3-beta-acety1-11-keto-beta-boswellic acid (akba), industrial manufacture and their uses
|
WO2003080149A2
(en)
|
2002-03-20 |
2003-10-02 |
Mannkind Corporation |
Inhalation apparatus
|
US7235249B2
(en)
*
|
2002-03-28 |
2007-06-26 |
The Procter & Gamble Company |
Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions
|
DE10228680A1
(de)
*
|
2002-06-27 |
2004-01-22 |
Holden Development Limited, Tortola |
Grundlage für transdermale Formulierungen (PTF)
|
US7099713B2
(en)
|
2002-06-28 |
2006-08-29 |
Battelle Memorial Institute |
Skin conduction and transport systems
|
AU2002950713A0
(en)
*
|
2002-08-09 |
2002-09-12 |
Vital Health Sciences Pty Ltd |
Carrier
|
US20040062794A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Lee Shulman |
17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
|
US9035123B2
(en)
|
2002-10-01 |
2015-05-19 |
The Procter & Gamble Company |
Absorbent article having a lotioned topsheet
|
AU2003296335A1
(en)
*
|
2002-12-06 |
2004-06-30 |
Board Of Regents, The University Of Texas System |
Compositions and methods related to lipid:emodin formulations
|
CA2513427C
(en)
*
|
2003-01-17 |
2012-03-27 |
Vital Health Sciences Pty Ltd. |
Compounds having anti-proliferative properties
|
WO2004068107A2
(en)
*
|
2003-01-21 |
2004-08-12 |
Transform Pharmaceuticals, Inc |
Apparatus and method for transcellular testing
|
ES2535045T3
(es)
|
2003-04-10 |
2015-05-04 |
Vanderbilt Royalty Sub L.P. |
Usos y composiciones para administración de capsaicina
|
US7052715B2
(en)
*
|
2003-04-11 |
2006-05-30 |
All Natural Fmg, Inc. |
Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
|
US7033998B2
(en)
*
|
2003-04-11 |
2006-04-25 |
All Natural Fmg, Inc. |
Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
|
AU2003901815A0
(en)
*
|
2003-04-15 |
2003-05-01 |
Vital Health Sciences Pty Ltd |
Phosphate derivatives
|
FR2855753B1
(fr)
*
|
2003-06-03 |
2007-09-14 |
Dermo Cosmologie Lab De |
Composition a base de diosgenine applicable par voie topique
|
US20050058673A1
(en)
|
2003-09-09 |
2005-03-17 |
3M Innovative Properties Company |
Antimicrobial compositions and methods
|
MXPA06003316A
(es)
|
2003-10-10 |
2006-06-08 |
Antares Pharma Ipl Ag |
Formulacion farmaceutica transdermica para minimizar los residuos en la piel.
|
US6998109B1
(en)
|
2004-01-07 |
2006-02-14 |
Pearson Research & Development Limited |
Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity
|
WO2005074946A1
(en)
*
|
2004-02-10 |
2005-08-18 |
Adenobio N.V. |
Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
|
US20050271597A1
(en)
*
|
2004-02-13 |
2005-12-08 |
Keith Alec D |
Prostate hypertrophy treatment composition and method
|
EP1732577B1
(en)
*
|
2004-02-23 |
2013-04-10 |
Strategic Science & Technologies, LLC |
Topical delivery of l-arginine to improve body and skin appearance
|
JP4847437B2
(ja)
*
|
2004-03-03 |
2011-12-28 |
バイタル ヘルス サイエンシズ プロプライアタリー リミティド |
アルカロイド製剤
|
EP1737378A2
(en)
*
|
2004-04-02 |
2007-01-03 |
Baylor College of Medicine |
Novel modification of medical prostheses
|
US20050226827A1
(en)
*
|
2004-04-09 |
2005-10-13 |
Thienna Ho |
Skin lightening composition
|
US20110028548A1
(en)
*
|
2004-04-19 |
2011-02-03 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
WO2005102307A2
(en)
*
|
2004-04-19 |
2005-11-03 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
US9226909B2
(en)
|
2004-04-19 |
2016-01-05 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US20050272700A1
(en)
*
|
2004-05-10 |
2005-12-08 |
Servet Buyuktimkin |
Topical treatment and prevention of human papilloma virus (HPV) infection
|
JP5078014B2
(ja)
|
2004-08-20 |
2012-11-21 |
マンカインド コーポレイション |
ジケトピペラジン合成の触媒反応
|
MX2007002189A
(es)
|
2004-08-23 |
2008-01-11 |
Mannkind Corp |
Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
|
CN101076348A
(zh)
*
|
2004-10-08 |
2007-11-21 |
克里纽沃药物有限公司 |
用于在受试者中诱导黑素原生成的组合物和方法
|
US9415034B2
(en)
*
|
2005-01-05 |
2016-08-16 |
National Defense Medical Center |
Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
|
BRPI0607461A2
(pt)
*
|
2005-02-14 |
2009-09-08 |
Neurogesx Inc |
dispositivo para liberação de agonistas de trpv1
|
KR20070108382A
(ko)
*
|
2005-03-03 |
2007-11-09 |
바이탈 헬스 사이언시즈 피티와이 리미티드 |
항암성 화합물
|
MX2007010908A
(es)
|
2005-03-10 |
2007-12-05 |
3M Innovative Properties Co |
Composiciones antimicrobianas que comprenden esteres de acidos hidroxicarboxilicos.
|
BRPI0608690B8
(pt)
|
2005-03-10 |
2021-05-25 |
3M Innovative Properties Co |
uso de uma composição antimicrobiana
|
US20060222690A1
(en)
*
|
2005-03-30 |
2006-10-05 |
Bley Keith R |
Low-concentration capsaicin patch and methods for treating neuropathic pain
|
US7563464B1
(en)
|
2005-04-22 |
2009-07-21 |
Bruce Eric Hudkins |
Treatment of mucosal membranes utilizing phytoestrogen
|
US7252834B2
(en)
|
2005-04-25 |
2007-08-07 |
Clemson University Research Foundation (Curf) |
Elastin stabilization of connective tissue
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
MX2007015949A
(es)
*
|
2005-06-17 |
2008-03-07 |
Vital Health Sciences Pty Ltd |
Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
|
US7803404B2
(en)
*
|
2005-09-14 |
2010-09-28 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
EP1940346A2
(en)
*
|
2005-09-30 |
2008-07-09 |
The Procter and Gamble Company |
Composition for regulation of mammalian keratinous tissue
|
US8911751B2
(en)
|
2005-10-11 |
2014-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions for nasal delivery
|
US7920926B2
(en)
*
|
2005-12-09 |
2011-04-05 |
Apsara Medical Corporation |
Method and apparatus for carrying out the controlled heating of tissue in the region of dermis
|
US20070196301A1
(en)
|
2005-12-21 |
2007-08-23 |
L'oreal |
Cosmetic composition with a volumizing effect
|
FR2894811B1
(fr)
†
|
2005-12-21 |
2008-02-22 |
Oreal |
Composition cosmetique a effet volumateur
|
TW200800223A
(en)
*
|
2005-12-21 |
2008-01-01 |
Shire Pharmaceuticals Inc |
Transdermal delivery of meptazinol
|
EP1973547A1
(en)
*
|
2005-12-23 |
2008-10-01 |
Vital Health Sciences Pty Ltd. |
Compounds having cytokine modulating properties
|
US20100112048A1
(en)
*
|
2006-01-24 |
2010-05-06 |
Majid Fotuhi |
Dosage Regimen and Medicament For Reducing Risk of Onset or Progression of Dementia by Administration of Specific Vitamins and Nsaid
|
IN2015DN00888A
(da)
|
2006-02-22 |
2015-07-10 |
Mannkind Corp |
|
NZ571460A
(en)
|
2006-04-21 |
2010-10-29 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
US20090238763A1
(en)
|
2006-07-09 |
2009-09-24 |
Chongxi Yu |
High penetration compositions and uses thereof
|
US20090221703A1
(en)
|
2006-07-09 |
2009-09-03 |
Chongxi Yu |
High penetration composition and uses thereof
|
EP2045306B1
(en)
*
|
2006-07-14 |
2011-09-21 |
National University Corporation Hokkaido University |
Supercooling promoting agent
|
DK2041068T3
(da)
|
2006-07-18 |
2017-02-27 |
Techfields Biochem Co Ltd |
Positivt ladede, vandopløselige prodrugs af ibuprofen med meget hurtig hudpenetrationshastighed
|
ES2472545T3
(es)
|
2006-07-25 |
2014-07-01 |
Techfields Biochem Co. Ltd |
Profármacos de diclofenaco solubles en agua con carga positiva y con una tasa de penetración en piel muy rápida
|
HUE028425T2
(en)
|
2006-08-08 |
2016-12-28 |
Techfields Biochem Co Ltd |
Positive charged water-soluble prodrugs of aryl and heteroarylacetic acids with very fast skin penetration rate
|
PL2084132T3
(pl)
|
2006-09-03 |
2019-03-29 |
Techfields Biochem Co. Ltd |
Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry
|
EP2746251A3
(en)
|
2006-09-03 |
2014-07-02 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of acetaminophen and related compunds with very fast skin penetration rate
|
US20080075793A1
(en)
*
|
2006-09-21 |
2008-03-27 |
Dunshee Wayne K |
Antiviral compositions and methods of use
|
CA2665081C
(en)
*
|
2006-10-02 |
2015-12-01 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
|
EP2084165B1
(en)
|
2006-10-11 |
2013-06-12 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
|
US20080097557A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Apsara Medical Corporation |
Method and apparatus for carrying out the controlled heating of tissue in the region of dermis
|
EP2059125B1
(en)
*
|
2006-10-23 |
2013-08-14 |
Ecolab Inc. |
Virucidal composition
|
BRPI0807943A2
(pt)
*
|
2007-02-15 |
2014-10-21 |
Derma Young Ltd |
Composição farmacêutica ou nutracêutica e métodos para melhorar a administração de um ingrediente farmacêutico pela mucosa oral e para supressão de apetite
|
WO2008149181A1
(en)
|
2007-06-04 |
2008-12-11 |
Techfields Inc |
Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
|
US8003621B2
(en)
|
2007-09-14 |
2011-08-23 |
Nitto Denko Corporation |
Drug carriers
|
WO2009064806A1
(en)
*
|
2007-11-12 |
2009-05-22 |
Endologix, Inc. |
Method and agent for in-situ stabilization of vascular tissue
|
GB0801119D0
(en)
|
2008-01-22 |
2008-02-27 |
Barry Callebaut Ag |
Composition
|
WO2009105265A2
(en)
*
|
2008-02-21 |
2009-08-27 |
Vatrix Medical, Inc. |
Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
|
US20110038899A1
(en)
*
|
2008-03-28 |
2011-02-17 |
Garry Thomas Gwozdz |
Pharmaceutical Solutions and Method for Solublilizing Therapeutic Agents
|
KR101933816B1
(ko)
|
2008-06-13 |
2019-03-29 |
맨카인드 코포레이션 |
건조 분말 흡입기 및 약물 투여 시스템
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
WO2009155581A1
(en)
|
2008-06-20 |
2009-12-23 |
Mannkind Corporation |
An interactive apparatus and method for real-time profiling of inhalation efforts
|
EP2429481A4
(en)
|
2008-06-25 |
2014-08-13 |
Elc Man Llc |
METHOD AND COMPOSITIONS FOR IMPROVING THE APPEARANCE OF SKIN AND BODY
|
US20100016833A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Ogle Matthew F |
Devices for the Treatment of Vascular Aneurysm
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
WO2010029578A2
(en)
|
2008-09-15 |
2010-03-18 |
Ganga Raju Gokaraju |
Synergistic anti-inflammatory compositions comprising boswellia serrata extracts
|
US20100119605A1
(en)
*
|
2008-11-12 |
2010-05-13 |
Isenburg Jason C |
Compositions for tissue stabilization
|
CN108191846B
(zh)
|
2008-12-04 |
2021-08-20 |
于崇曦 |
高穿透性组合物及其应用
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
PL2405963T3
(pl)
|
2009-03-11 |
2014-04-30 |
Mannkind Corp |
Urządzenie, układ i sposób pomiaru oporu inhalatora
|
BRPI1013154B1
(pt)
|
2009-06-12 |
2020-04-07 |
Mannkind Corp |
Micropartículas de dicetopiperazina com áreas de superfície específicas definidas, pó seco compreendendo as referidas micropartículas, método para formação das referidasmicropartículas e formação de micropartículas de fumaril diacetopiperazina, uso das referidas micropartículas e sistema de inalação
|
WO2010151241A1
(en)
|
2009-06-24 |
2010-12-29 |
Strategic Science & Technologies, Llc |
Topical composition containing naproxen
|
US11684624B2
(en)
|
2009-06-24 |
2023-06-27 |
Strategic Science & Technologies, Llc |
Treatment of erectile dysfunction and other indications
|
WO2012092528A1
(en)
|
2010-12-29 |
2012-07-05 |
Strategic Science & Technologies, Llc |
Treatment of erectile dysfunction and other indications
|
MA33454B1
(fr)
*
|
2009-06-24 |
2012-07-03 |
Strategic Science & Tech Llc |
Composition topique contenant de l'ibuprofène
|
US20110218517A1
(en)
*
|
2009-10-09 |
2011-09-08 |
Ogle Matthew F |
In vivo chemical stabilization of vulnerable plaque
|
US8444624B2
(en)
*
|
2009-10-19 |
2013-05-21 |
Vatrix Medical, Inc. |
Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
EP2512231B1
(en)
|
2009-12-16 |
2016-12-07 |
Ecolab Inc. |
Composition in form of a gel for the virucidal disinfection of mammalian skin
|
AU2011213557B2
(en)
|
2010-02-05 |
2015-05-07 |
Phosphagenics Limited |
Carrier comprising non-neutralised tocopheryl phosphate
|
EP2536288B1
(en)
*
|
2010-02-15 |
2022-06-22 |
Laila Nutraceuticals |
A novel boswellia low polar gum resin extract and its synergistic compositions
|
US8828377B2
(en)
|
2010-03-15 |
2014-09-09 |
Laila Nutraceuticals |
Boswellia oil, its fractions and compositions for enhancing brain function
|
CA2794734C
(en)
|
2010-03-30 |
2017-12-12 |
Phosphagenics Limited |
Transdermal delivery patch
|
MX359281B
(es)
|
2010-06-21 |
2018-09-21 |
Mannkind Corp |
Sistema y metodos para suministrar un farmaco en polvo seco.
|
CN105878172A
(zh)
|
2010-12-29 |
2016-08-24 |
战略科学与技术有限责任公司 |
治疗变态反应和其它适应症的系统和方法
|
US8911468B2
(en)
|
2011-01-31 |
2014-12-16 |
Vatrix Medical, Inc. |
Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
|
TR201101374A1
(tr)
|
2011-02-14 |
2012-09-21 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Flurbiprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
|
EP2685992A4
(en)
|
2011-03-15 |
2014-09-10 |
Phosphagenics Ltd |
AMINO-QUINOLINES AS KINASE INHIBITORS
|
MX353285B
(es)
|
2011-04-01 |
2018-01-05 |
Mannkind Corp |
Paquete de blister para cartuchos farmaceuticos.
|
TR201103183A1
(tr)
*
|
2011-04-01 |
2012-10-22 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Ketoprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
|
TR201103770A1
(tr)
|
2011-04-19 |
2012-11-21 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Nimesulid ve metilsülfonilmetanin topikalfarmasötik bileşimleri.
|
JP2014516695A
(ja)
|
2011-05-18 |
2014-07-17 |
バトリックス・メディカル・インコーポレイテッド |
血管安定化用被覆バルーン
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
IN2014DN03093A
(da)
|
2011-10-24 |
2015-05-15 |
Mannkind Corp |
|
PL2782584T3
(pl)
|
2011-11-23 |
2021-12-13 |
Therapeuticsmd, Inc. |
Naturalne skojarzone hormonalne formulacje i terapie zastępcze
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
WO2013089656A1
(en)
|
2011-12-16 |
2013-06-20 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Topical pharmaceutical compositions of thiocolchicoside and methylsulfonylmethane
|
AU2013262320B2
(en)
|
2012-05-16 |
2018-02-22 |
Techfields Pharma Co., Ltd. |
High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US9283241B2
(en)
|
2012-07-10 |
2016-03-15 |
Clemson University |
Treatment to render implants resistant to diabetes
|
SG10201605800UA
(en)
|
2012-07-12 |
2016-09-29 |
Mannkind Corp |
Dry powder drug delivery system and methods
|
WO2014024193A1
(en)
*
|
2012-08-07 |
2014-02-13 |
Prodel Pharma Ltd. |
Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
KR102499439B1
(ko)
|
2013-03-15 |
2023-02-13 |
맨카인드 코포레이션 |
미세결정성 디케토피페라진 조성물 및 방법
|
CA2918369C
(en)
|
2013-07-18 |
2021-06-29 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
WO2015021064A1
(en)
|
2013-08-05 |
2015-02-12 |
Mannkind Corporation |
Insufflation apparatus and methods
|
EP3036004B1
(en)
*
|
2013-08-21 |
2022-12-07 |
Concordia University |
Dendrimer-resveratrol complex
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10206932B2
(en)
|
2014-05-22 |
2019-02-19 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
WO2016018993A1
(en)
|
2014-07-29 |
2016-02-04 |
Therapeuticsmd, Inc. |
Transdermal cream
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US11510859B2
(en)
*
|
2015-07-16 |
2022-11-29 |
Marinomed Biotech Ag |
Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
US20180235870A1
(en)
*
|
2015-08-17 |
2018-08-23 |
Delivra Inc. |
Transdermal formulations for delivery of berberine compounds, and their use in the treatment of berberine-responsive diseases and conditions
|
WO2017048807A1
(en)
|
2015-09-17 |
2017-03-23 |
Jrx Biotechnology, Inc. |
Approaches for improving skin hydration or moisturization
|
CA3007587C
(en)
|
2015-12-09 |
2023-12-05 |
Phosphagenics Limited |
Pharmaceutical formulation
|
US10688069B2
(en)
|
2016-03-31 |
2020-06-23 |
REV Pharmaceuticals LLC |
Sports health performance composition
|
AU2017239645A1
(en)
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
CN106349206B
(zh)
*
|
2016-08-29 |
2018-09-21 |
珀莱雅化妆品股份有限公司 |
一种从毛喉鞘蕊花中提取福斯高林的制备方法
|
BR112019012946A2
(pt)
|
2016-12-21 |
2019-11-26 |
Avecho Biotechnology Ltd |
processo
|
US10385297B2
(en)
|
2017-03-16 |
2019-08-20 |
The Procter & Gamble Company |
Methods for making encapsulate-containing product compositions
|
US11103465B2
(en)
|
2017-11-22 |
2021-08-31 |
Ted's Brain Science, Inc. |
Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|